Personalised Health Care, 1st ed. 2021
Fostering Precision Medicine Advancements for Gaining Population Health Impact
SpringerBriefs in Public Health Series

Practitioners are increasingly adopting a personalised medicine approach to individually tailored patient care, especially disease diagnosis and treatment with the use of biomarkers. However, development and implementation of such approaches to chronic disease prevention need further investigation and concerted efforts for proper use in healthcare systems. This book provides high-quality, multidisciplinary knowledge from research in personalised medicine, specifically personalised prevention of chronic disease. It addresses different perspectives of prevention in the field, and is the outcome of a four-year work of the Personalized prevention of Chronic Disease (PRECeDI) Consortium, a multi-disciplinary and multi-professional team of experts. 

The Consortium jointly agreed to document and address the five aspects or domains of personalised medicine and prevention as individual chapters: 

• Identification of biomarkers for theprevention of chronic disease
• Evaluation of predictive genomic applications
• Ethico-legal and policy issues surrounding personalised medicine
• Roles and responsibilities of stakeholders in informing healthy individuals on their genome: a sociotechnical analysis
• Identification of organisational models for the provision of predictive genomic applications

The book focuses on the Consortium's recommendations that are derived from each of these domains based on up-to-date evidence and research that the authors write, follow, and systematically organise and report.

Personalisation of health care is, eventually, a driver of innovation in research and healthcare systems. With this SpringerBrief on Personalised Health Care: Fostering Precision Medicine Advancements for Gaining Population Health Impact, the Consortium provides further evidence of the clinical validity and utility of personalised medicine with special emphasis on the prevention of chronic diseases. The book is a useful resource for policy makers, industry and healthcare professionals, scientists, technology-sector professionals, investors, citizens, and private companies that need proper advice to realise the potential of personalised medicine.

Stefania Boccia, PhD, DSc, MS, is Full professor of Hygiene, Preventive Medicine and Public Health at Università Cattolica del Sacro Cuore (UCSC) in Rome, Italy. She is the Director of the Section of Hygiene of the Department of Health Science and Public Health of UCSC and President of the Public Health Epidemiology Section of European Public Health Association (EUPHA). A Biologist by training and Specialist in Clinical Pathology, she obtained a Master of Science in Epidemiology and Biostatistics and a Doctor of Science and PhD in Genetic Epidemiology at the Erasmus MC in Rotterdam, the Netherlands. From 2016 to 2018 she was Adjunct Professor at Mount Sinai Medical School in New York, NY, USA. In 2018 she founded the spin-off “Vihtali srl” (Value In Health Technology and Academy for Leadership & Innovation) at UCSC. She currently coordinates the project titled “European network staff eXchange for integrAting precision health in the health Care sysTems” (ExACT) funded by the European Commission (EC) within the H2020 Marie-Slodowska Curie projects (MSCA-RISE). She is currently partner of several EU-funded projects; among them is  “Integrating China in the International Consortium for Personalised Medicine” (IC2PerMed, CSA) as a member of the Coordinating group. She is author and co-author of 216 scientific publications; her h-index (Scopus) is 37 and citation count is 5350.

Róza Ádány, MD, PhD, DSc, is a medical doctor with specialization in the field of preventive medicine and public health. She is Professor of public health at the University of Debrecen, Hungary; founding Dean of the Faculty of Public Health; leader of the Public Health Research Group funded by the Hungarian Academy of Sciences; head of the WHO Collaborating Centre on Vulnerability and Health; and President of the Public Health Genomics Section of the European Public Health Association. She also acts as president of the Hungarian Associatio